Scinovex
article

Vaccines for SARS-CoV-2: How have they changed the landscape of COVID-19 pandemic

International Journal of Immunology Research · 2022 · Vol. 4(1) · pp. 9–13

Abstract

COVID-19 pandemic has brought about huge disruptions to our lives. COVID-19 vaccines have been developed and manufactured in a record timeframe. The use of COVID-19 vaccines has mitigated morbidity and mortality associated with COVID-19 to a large extent. This happened because these vaccines have been able to elicit immune memory and longstanding cell-mediated immunity in vaccinated individuals. Vaccine hesitancy and unequitable distribution of vaccines have been the two stumbling blocks to widespread vaccination of populations. As SARS-CoV-2 seems to enter endemic phase, there is need for vaccines administered through respiratory route, which hopefully would elicit mucosal immunity and sterilizing immunity eventually stopping interhuman transmission of the virus.

SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyImmune responses and vaccinationsPandemicImmunityCoronavirus disease 2019 (COVID-19)VaccinationVirologyTransmission (telecommunications)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakMedicineHerd immunity
Citations
0
FWCI
0.00
field-weighted impact
References
0
Percentile
20%
vs. same field & year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.